nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS2—melanoma	0.84	1	CbGaD
Nepafenac—PTGS2—leg—melanoma	0.00572	0.162	CbGeAlD
Nepafenac—Teratogenicity—Carmustine—melanoma	0.00521	0.113	CcSEcCtD
Nepafenac—PTGS2—hindlimb—melanoma	0.00511	0.145	CbGeAlD
Nepafenac—PTGS2—appendage—melanoma	0.00438	0.124	CbGeAlD
Nepafenac—Conjunctival oedema—Carmustine—melanoma	0.00394	0.0851	CcSEcCtD
Nepafenac—PTGS2—skin epidermis—melanoma	0.00364	0.104	CbGeAlD
Nepafenac—Diclofenac—CXCR1—melanoma	0.00312	0.226	CrCbGaD
Nepafenac—PTGS1—endothelium—melanoma	0.00277	0.0786	CbGeAlD
Nepafenac—Ketoprofen—CXCR1—melanoma	0.00276	0.2	CrCbGaD
Nepafenac—PTGS2—endothelium—melanoma	0.00264	0.0751	CbGeAlD
Nepafenac—PTGS1—blood vessel—melanoma	0.00255	0.0725	CbGeAlD
Nepafenac—Impaired healing—Carmustine—melanoma	0.00253	0.0546	CcSEcCtD
Nepafenac—PTGS2—blood vessel—melanoma	0.00244	0.0693	CbGeAlD
Nepafenac—Visual acuity reduced—Temozolomide—melanoma	0.00178	0.0384	CcSEcCtD
Nepafenac—Arthritis—Vemurafenib—melanoma	0.00154	0.0334	CcSEcCtD
Nepafenac—Lacrimation—Docetaxel—melanoma	0.00119	0.0258	CcSEcCtD
Nepafenac—PTGS1—skin of body—melanoma	0.00118	0.0336	CbGeAlD
Nepafenac—PTGS2—skin of body—melanoma	0.00113	0.0321	CbGeAlD
Nepafenac—PTGS1—mammalian vulva—melanoma	0.00108	0.0306	CbGeAlD
Nepafenac—Dry eye—Temozolomide—melanoma	0.000975	0.0211	CcSEcCtD
Nepafenac—Eye disorder—Vemurafenib—melanoma	0.00097	0.021	CcSEcCtD
Nepafenac—Dermatitis atopic—Docetaxel—melanoma	0.000949	0.0205	CcSEcCtD
Nepafenac—Angiopathy—Vemurafenib—melanoma	0.000941	0.0203	CcSEcCtD
Nepafenac—Arthritis—Bleomycin—melanoma	0.000935	0.0202	CcSEcCtD
Nepafenac—Diabetes mellitus—Carmustine—melanoma	0.000912	0.0197	CcSEcCtD
Nepafenac—Eye pain—Carmustine—melanoma	0.000879	0.019	CcSEcCtD
Nepafenac—Eye pain—Temozolomide—melanoma	0.000849	0.0184	CcSEcCtD
Nepafenac—Eye irritation—Docetaxel—melanoma	0.000822	0.0178	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—melanoma	0.000786	0.0571	CrCbGaD
Nepafenac—PTGS1—head—melanoma	0.000771	0.0219	CbGeAlD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000764	0.0165	CcSEcCtD
Nepafenac—Lacrimation increased—Docetaxel—melanoma	0.000762	0.0165	CcSEcCtD
Nepafenac—PTGS2—head—melanoma	0.000737	0.0209	CbGeAlD
Nepafenac—Nervous system disorder—Vemurafenib—melanoma	0.000723	0.0156	CcSEcCtD
Nepafenac—Skin disorder—Vemurafenib—melanoma	0.000716	0.0155	CcSEcCtD
Nepafenac—Blood pressure increased—Docetaxel—melanoma	0.000702	0.0152	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—melanoma	0.000697	0.0505	CrCbGaD
Nepafenac—Ketorolac—PTGS2—melanoma	0.000647	0.0469	CrCbGaD
Nepafenac—Gastrointestinal disorder—Vemurafenib—melanoma	0.000636	0.0138	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—melanoma	0.00062	0.045	CrCbGaD
Nepafenac—Sinusitis—Temozolomide—melanoma	0.000554	0.012	CcSEcCtD
Nepafenac—Hypersensitivity—Vemurafenib—melanoma	0.000543	0.0117	CcSEcCtD
Nepafenac—PTGS1—lymph node—melanoma	0.00054	0.0153	CbGeAlD
Nepafenac—Tiaprofenic acid—PTGS2—melanoma	0.000527	0.0382	CrCbGaD
Nepafenac—Pruritus—Vemurafenib—melanoma	0.000522	0.0113	CcSEcCtD
Nepafenac—PTGS2—lymph node—melanoma	0.000516	0.0147	CbGeAlD
Nepafenac—Eye disorder—Carmustine—melanoma	0.000513	0.0111	CcSEcCtD
Nepafenac—Eye disorder—Temozolomide—melanoma	0.000496	0.0107	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—melanoma	0.00049	0.0355	CrCbGaD
Nepafenac—Dizziness—Vemurafenib—melanoma	0.000487	0.0105	CcSEcCtD
Nepafenac—Angiopathy—Temozolomide—melanoma	0.000481	0.0104	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—melanoma	0.000479	0.0348	CrCbGaD
Nepafenac—Immune system disorder—Temozolomide—melanoma	0.000479	0.0104	CcSEcCtD
Nepafenac—Vomiting—Vemurafenib—melanoma	0.000469	0.0101	CcSEcCtD
Nepafenac—Headache—Vemurafenib—melanoma	0.000462	0.00998	CcSEcCtD
Nepafenac—Vision blurred—Carmustine—melanoma	0.00045	0.00973	CcSEcCtD
Nepafenac—Nausea—Vemurafenib—melanoma	0.000438	0.00947	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—melanoma	0.000437	0.0317	CrCbGaD
Nepafenac—Vision blurred—Temozolomide—melanoma	0.000435	0.0094	CcSEcCtD
Nepafenac—Salsalate—PTGS2—melanoma	0.000417	0.0302	CrCbGaD
Nepafenac—Hypertension—Carmustine—melanoma	0.000412	0.00891	CcSEcCtD
Nepafenac—Mebendazole—ABCB1—melanoma	0.000399	0.029	CrCbGaD
Nepafenac—Hypertension—Temozolomide—melanoma	0.000399	0.00862	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00039	0.00844	CcSEcCtD
Nepafenac—Dry mouth—Temozolomide—melanoma	0.000384	0.00831	CcSEcCtD
Nepafenac—Nervous system disorder—Temozolomide—melanoma	0.000369	0.00799	CcSEcCtD
Nepafenac—Skin disorder—Temozolomide—melanoma	0.000366	0.00791	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—melanoma	0.000344	0.025	CrCbGaD
Nepafenac—Gastrointestinal disorder—Carmustine—melanoma	0.000337	0.00728	CcSEcCtD
Nepafenac—Eye disorder—Docetaxel—melanoma	0.00033	0.00712	CcSEcCtD
Nepafenac—Hypersensitivity—Bleomycin—melanoma	0.000329	0.00711	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Temozolomide—melanoma	0.000325	0.00703	CcSEcCtD
Nepafenac—Angiopathy—Docetaxel—melanoma	0.00032	0.00692	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—melanoma	0.000319	0.0232	CrCbGaD
Nepafenac—Immune system disorder—Docetaxel—melanoma	0.000319	0.00689	CcSEcCtD
Nepafenac—Pruritus—Bleomycin—melanoma	0.000316	0.00683	CcSEcCtD
Nepafenac—Hypersensitivity—Dactinomycin—melanoma	0.000307	0.00663	CcSEcCtD
Nepafenac—Fenoprofen—ALB—melanoma	0.000307	0.0223	CrCbGaD
Nepafenac—Hypersensitivity—Carmustine—melanoma	0.000287	0.00621	CcSEcCtD
Nepafenac—Vomiting—Bleomycin—melanoma	0.000284	0.00614	CcSEcCtD
Nepafenac—Hypersensitivity—Temozolomide—melanoma	0.000278	0.006	CcSEcCtD
Nepafenac—Pruritus—Temozolomide—melanoma	0.000267	0.00576	CcSEcCtD
Nepafenac—Nausea—Bleomycin—melanoma	0.000265	0.00573	CcSEcCtD
Nepafenac—Hypertension—Docetaxel—melanoma	0.000265	0.00573	CcSEcCtD
Nepafenac—Vomiting—Dactinomycin—melanoma	0.000265	0.00572	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00026	0.00561	CcSEcCtD
Nepafenac—Dizziness—Carmustine—melanoma	0.000258	0.00557	CcSEcCtD
Nepafenac—Oxcarbazepine—ALB—melanoma	0.000257	0.0187	CrCbGaD
Nepafenac—Dry mouth—Docetaxel—melanoma	0.000256	0.00553	CcSEcCtD
Nepafenac—Dizziness—Temozolomide—melanoma	0.000249	0.00539	CcSEcCtD
Nepafenac—Vomiting—Carmustine—melanoma	0.000248	0.00536	CcSEcCtD
Nepafenac—Nausea—Dactinomycin—melanoma	0.000247	0.00535	CcSEcCtD
Nepafenac—Nervous system disorder—Docetaxel—melanoma	0.000246	0.00531	CcSEcCtD
Nepafenac—Headache—Carmustine—melanoma	0.000244	0.00528	CcSEcCtD
Nepafenac—Skin disorder—Docetaxel—melanoma	0.000243	0.00526	CcSEcCtD
Nepafenac—Vomiting—Temozolomide—melanoma	0.00024	0.00518	CcSEcCtD
Nepafenac—Headache—Temozolomide—melanoma	0.000236	0.0051	CcSEcCtD
Nepafenac—Nausea—Carmustine—melanoma	0.000232	0.00501	CcSEcCtD
Nepafenac—Diclofenac—PTGS2—melanoma	0.000229	0.0166	CrCbGaD
Nepafenac—Nausea—Temozolomide—melanoma	0.000224	0.00484	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Docetaxel—melanoma	0.000216	0.00468	CcSEcCtD
Nepafenac—Diclofenac—ALB—melanoma	0.000204	0.0148	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—melanoma	0.000203	0.0147	CrCbGaD
Nepafenac—Diclofenac—ABCB1—melanoma	0.000195	0.0142	CrCbGaD
Nepafenac—Hypersensitivity—Docetaxel—melanoma	0.000185	0.00399	CcSEcCtD
Nepafenac—Ketoprofen—ALB—melanoma	0.000181	0.0131	CrCbGaD
Nepafenac—Pruritus—Docetaxel—melanoma	0.000177	0.00383	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NRAS—melanoma	0.000172	0.00265	CbGpPWpGaD
Nepafenac—Carbamazepine—ABCB1—melanoma	0.000167	0.0121	CrCbGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—melanoma	0.000166	0.00255	CbGpPWpGaD
Nepafenac—Dizziness—Docetaxel—melanoma	0.000166	0.00358	CcSEcCtD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—melanoma	0.000164	0.00252	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000163	0.00251	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—RAC1—melanoma	0.000163	0.0025	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—melanoma	0.000161	0.00247	CbGpPWpGaD
Nepafenac—Vomiting—Docetaxel—melanoma	0.000159	0.00344	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	0.000157	0.00241	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—melanoma	0.000157	0.00241	CbGpPWpGaD
Nepafenac—Headache—Docetaxel—melanoma	0.000157	0.00339	CcSEcCtD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000155	0.00239	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDK2—melanoma	0.000154	0.00237	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000153	0.00235	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—melanoma	0.000151	0.00232	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—melanoma	0.00015	0.0023	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TLR4—melanoma	0.000149	0.00229	CbGpPWpGaD
Nepafenac—Nausea—Docetaxel—melanoma	0.000149	0.00322	CcSEcCtD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—melanoma	0.000148	0.00228	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN2A—melanoma	0.000146	0.00225	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDK4—melanoma	0.000146	0.00224	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—NFKB1—melanoma	0.000144	0.00222	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—BCL2—melanoma	0.000144	0.00221	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACER3—melanoma	0.000144	0.00221	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—ICAM1—melanoma	0.000143	0.0022	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS2—melanoma	0.000142	0.00218	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—melanoma	0.00014	0.00215	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CD4—melanoma	0.000138	0.00212	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—melanoma	0.000138	0.00211	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MYO7A—melanoma	0.000136	0.00209	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000133	0.00204	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—UGT2B10—melanoma	0.000132	0.00202	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00013	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN1B—melanoma	0.00013	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.00013	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00013	0.00199	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—RB1—melanoma	0.000127	0.00195	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—melanoma	0.000126	0.00194	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000124	0.00191	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CCND1—melanoma	0.000124	0.0019	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HS3ST5—melanoma	0.000122	0.00188	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000122	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000121	0.00186	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000121	0.00185	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN1A—melanoma	0.00012	0.00184	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000119	0.00183	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.000117	0.0018	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HS3ST5—melanoma	0.000116	0.00178	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.000115	0.00176	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—NFKB1—melanoma	0.000115	0.00176	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACER3—melanoma	0.000114	0.00175	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.000113	0.00173	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—melanoma	0.000112	0.00172	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.000111	0.0017	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—melanoma	0.000109	0.00167	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—NRAS—melanoma	0.000107	0.00164	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.000105	0.00161	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—UGT2B10—melanoma	0.000104	0.0016	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000103	0.00158	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—melanoma	0.000101	0.00155	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	9.97e-05	0.00153	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	9.93e-05	0.00153	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—MYC—melanoma	9.92e-05	0.00152	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	9.88e-05	0.00152	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	9.84e-05	0.00151	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HS3ST5—melanoma	9.71e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CASP3—melanoma	9.68e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL2—melanoma	9.67e-05	0.00149	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCND1—melanoma	9.43e-05	0.00145	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	9.35e-05	0.00144	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLCB4—melanoma	9.27e-05	0.00142	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	9.24e-05	0.00142	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—KRAS—melanoma	9.17e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—melanoma	9.15e-05	0.00141	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	9.09e-05	0.0014	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—melanoma	9.05e-05	0.00139	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—melanoma	8.91e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIP4K2A—melanoma	8.71e-05	0.00134	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC6A11—melanoma	8.71e-05	0.00134	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	8.71e-05	0.00134	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	8.56e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTAP—melanoma	8.48e-05	0.0013	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.28e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	8.27e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TRRAP—melanoma	8.26e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CUL3—melanoma	8.26e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKR1B10—melanoma	8.03e-05	0.00123	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	7.87e-05	0.00121	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	7.81e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—HRAS—melanoma	7.79e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK3—melanoma	7.77e-05	0.00119	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MYC—melanoma	7.56e-05	0.00116	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LUM—melanoma	7.55e-05	0.00116	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PHGDH—melanoma	7.55e-05	0.00116	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	7.47e-05	0.00115	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HPSE—melanoma	7.41e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK1—melanoma	7.4e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—EGFR—melanoma	7.4e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.36e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLCB4—melanoma	7.36e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CUBN—melanoma	7.27e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	7.26e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	7.22e-05	0.00111	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—melanoma	7.19e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LUM—melanoma	7.16e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—melanoma	7.04e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SDHD—melanoma	7.02e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CSPG4—melanoma	7.02e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BSG—melanoma	7.02e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HPSE—melanoma	7.02e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIP4K2A—melanoma	6.92e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC6A11—melanoma	6.92e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CUBN—melanoma	6.89e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPAM—melanoma	6.8e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTAP—melanoma	6.73e-05	0.00103	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.72e-05	0.00103	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CSPG4—melanoma	6.66e-05	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.59e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.58e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPS3—melanoma	6.55e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SKI—melanoma	6.45e-05	0.00099	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.41e-05	0.000985	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.35e-05	0.000976	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TP53—melanoma	6.21e-05	0.000954	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	6.2e-05	0.000953	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	6.19e-05	0.000951	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	6.16e-05	0.000946	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PHGDH—melanoma	6e-05	0.000921	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LUM—melanoma	6e-05	0.000921	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HPSE—melanoma	5.88e-05	0.000903	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G6—melanoma	5.78e-05	0.000888	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CUBN—melanoma	5.77e-05	0.000887	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—melanoma	5.68e-05	0.000873	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.59e-05	0.000859	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SDHD—melanoma	5.57e-05	0.000856	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BSG—melanoma	5.57e-05	0.000856	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CSPG4—melanoma	5.57e-05	0.000856	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPAM—melanoma	5.4e-05	0.000829	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HDAC6—melanoma	5.32e-05	0.000818	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.29e-05	0.000812	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—VCAN—melanoma	5.19e-05	0.000798	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	5.14e-05	0.00079	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NPPA—melanoma	5.04e-05	0.000775	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	5.03e-05	0.000773	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	5.03e-05	0.000773	CbGpPWpGaD
Nepafenac—PTGS2—Disease—VCAN—melanoma	4.92e-05	0.000756	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.92e-05	0.000755	CbGpPWpGaD
Nepafenac—PTGS2—Disease—WNT5A—melanoma	4.89e-05	0.000751	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.79e-05	0.000736	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.75e-05	0.00073	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.75e-05	0.000729	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G6—melanoma	4.59e-05	0.000705	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP17A1—melanoma	4.38e-05	0.000673	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.37e-05	0.000671	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.32e-05	0.000664	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	4.27e-05	0.000656	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.22e-05	0.000649	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GNA11—melanoma	4.14e-05	0.000636	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—VCAN—melanoma	4.12e-05	0.000634	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FASN—melanoma	4.05e-05	0.000622	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC5A5—melanoma	3.98e-05	0.000612	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GAB2—melanoma	3.92e-05	0.000603	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.9e-05	0.0006	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GNAQ—melanoma	3.85e-05	0.000591	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD44—melanoma	3.85e-05	0.000591	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FASN—melanoma	3.84e-05	0.00059	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.77e-05	0.000579	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.77e-05	0.000579	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.73e-05	0.000574	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP1B1—melanoma	3.69e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HDAC2—melanoma	3.69e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FOXO4—melanoma	3.69e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CXCR4—melanoma	3.69e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD44—melanoma	3.65e-05	0.00056	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.57e-05	0.000548	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP17A1—melanoma	3.48e-05	0.000535	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.43e-05	0.000527	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.39e-05	0.00052	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT3—melanoma	3.37e-05	0.000517	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GNA11—melanoma	3.29e-05	0.000505	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.26e-05	0.0005	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FASN—melanoma	3.22e-05	0.000494	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC5A5—melanoma	3.16e-05	0.000486	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GNAQ—melanoma	3.05e-05	0.000469	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD44—melanoma	3.05e-05	0.000469	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCB1—melanoma	3.04e-05	0.000467	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.99e-05	0.00046	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB4—melanoma	2.97e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN2B—melanoma	2.95e-05	0.000453	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP1B1—melanoma	2.93e-05	0.00045	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD86—melanoma	2.85e-05	0.000438	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PRKCA—melanoma	2.8e-05	0.00043	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ERCC2—melanoma	2.77e-05	0.000426	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF1—melanoma	2.76e-05	0.000425	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDGFRA—melanoma	2.68e-05	0.000411	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKCA—melanoma	2.65e-05	0.000407	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERCC2—melanoma	2.63e-05	0.000404	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAP2K2—melanoma	2.59e-05	0.000398	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.58e-05	0.000397	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TERT—melanoma	2.46e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HLA-A—melanoma	2.46e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RAC1—melanoma	2.46e-05	0.000377	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCB1—melanoma	2.41e-05	0.00037	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIF1A—melanoma	2.36e-05	0.000362	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.3e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PRKCA—melanoma	2.22e-05	0.000341	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ERCC2—melanoma	2.2e-05	0.000338	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CG—melanoma	2.19e-05	0.000336	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—melanoma	2.14e-05	0.000329	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOTCH1—melanoma	2.12e-05	0.000326	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—melanoma	2.11e-05	0.000325	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD80—melanoma	2.08e-05	0.000319	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APC—melanoma	2.08e-05	0.000319	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KIT—melanoma	2.08e-05	0.000319	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGF—melanoma	2.05e-05	0.000315	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BRAF—melanoma	1.95e-05	0.0003	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CD—melanoma	1.93e-05	0.000296	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—melanoma	1.9e-05	0.000292	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAP2K1—melanoma	1.84e-05	0.000282	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CD—melanoma	1.82e-05	0.00028	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.82e-05	0.00028	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF2—melanoma	1.75e-05	0.000268	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CG—melanoma	1.74e-05	0.000267	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CB—melanoma	1.68e-05	0.000258	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—melanoma	1.68e-05	0.000258	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—melanoma	1.66e-05	0.000255	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MDM2—melanoma	1.63e-05	0.000251	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB2—melanoma	1.61e-05	0.000248	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CB—melanoma	1.59e-05	0.000244	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD4—melanoma	1.59e-05	0.000244	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CD—melanoma	1.53e-05	0.000235	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—melanoma	1.51e-05	0.000232	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1B—melanoma	1.49e-05	0.000229	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTEN—melanoma	1.45e-05	0.000223	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CTNNB1—melanoma	1.41e-05	0.000217	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN1A—melanoma	1.38e-05	0.000212	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PTEN—melanoma	1.37e-05	0.000211	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CB—melanoma	1.33e-05	0.000205	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—melanoma	1.23e-05	0.000189	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NRAS—melanoma	1.23e-05	0.000188	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK3—melanoma	1.17e-05	0.00018	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTEN—melanoma	1.15e-05	0.000177	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MYC—melanoma	1.14e-05	0.000175	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK1—melanoma	1.12e-05	0.000172	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGFR—melanoma	1.12e-05	0.000172	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KRAS—melanoma	1.06e-05	0.000162	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CA—melanoma	1.02e-05	0.000157	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CA—melanoma	9.7e-06	0.000149	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HRAS—melanoma	8.97e-06	0.000138	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—melanoma	8.59e-06	0.000132	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—melanoma	8.36e-06	0.000128	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CA—melanoma	8.12e-06	0.000125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—melanoma	7.92e-06	0.000122	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—melanoma	6.63e-06	0.000102	CbGpPWpGaD
